Medicare Part-D: Competition is the Best Way to Lower Prices

Kevin, MD links to this post about the HHS Secretary’s refusal to negotiate with pharmaceutical manufacturers for lower drug prices. At first glance, this policy seems crazy, but Joseph Antos of the American Enterprise Institute advises that it is indeed the wisest course:

Many people … say that Medicare should follow the lead of the U.S. Department of Veterans Affairs, which negotiates drug prices directly with manufacturers … That’s a seductive argument. But it ignores some key facts.First, the VA’s low prices are possible because it puts a tight limit on the number of drugs physicians may prescribe … Further, veterans using the VA system can’t go to their neighborhood pharmacy … It is unlikely that Medicare beneficiaries would accept such limitations.Most Part D plans are operated by pharmacy benefits managers (PBMs) that … negotiate prices on behalf of more than 50 million people with drug coverage … It’s hard to believe that Medicare, with 22 million Part D enrollees, could achieve discounts greater than a company with twice that number of customers.

So, when ALL of the facts are considered, the attitude of the HHS Secretary seems a lot more sensible. Thus, Antos concludes that “the best way to lower costs is through more competition, not more government management.” I think he’s right.

Post a Comment

Your email is never published nor shared. Required fields are marked *